Top compounds associated with response to NR1I2


Feature Type Standardized
Nominal ANOVA
mRNA thapsigargin gCSI pan-cancer AAC -0.19 0.001
mRNA phenformin GDSC1000 pan-cancer AAC 0.11 0.001
mRNA Cetuximab GDSC1000 pan-cancer AAC 0.12 0.002
mRNA selumetinib:navitoclax (8:1 mol/mol) CTRPv2 pan-cancer AAC 0.12 0.002
mRNA Docetaxel gCSI pan-cancer AAC -0.17 0.002
mRNA selumetinib:decitabine (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.11 0.002
mRNA BRD-K84807411 CTRPv2 pan-cancer AAC 0.23 0.003
mRNA selumetinib:piperlongumine (8:1 mol/mol) CTRPv2 pan-cancer AAC 0.11 0.003
mRNA Carboplatin CTRPv2 pan-cancer AAC 0.11 0.004
mRNA YM-155 CTRPv2 pan-cancer AAC -0.12 0.004
Download CSV